| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8216724 | International Journal of Radiation Oncology*Biology*Physics | 2015 | 25 Pages |
Abstract
Our findings suggest that HDR brachytherapy is safe and feasible for peripheral locally advanced NSCLC, justifying a phase 2 clinical trial.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Li MD, Jian-wen MD, Sheng PhD, Hui-Qun MD, Qing-Lian PhD, Li-Jia MD, Chang-Ling MD, Pei-Rong MD, Hong-Ru MD, Hao-Wen MD, Bo MD, Huai-Lin MD, Yue MD, Jing-Bo MD,